Drug Resistance, Multiple
"Drug Resistance, Multiple" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Simultaneous resistance to several structurally and functionally distinct drugs.
Concept/Terms
Drug Resistance, Multiple- Drug Resistance, Multiple
- Multiple Drug Resistance
- Resistance, Multiple Drug
- Multi-Drug Resistance
- Multidrug Resistance
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple".
This graph shows the total number of publications written about "Drug Resistance, Multiple" by people in Harvard Catalyst Profiles by year, and whether "Drug Resistance, Multiple" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 7 | 10 | 17 |
| 1996 | 3 | 6 | 9 |
| 1997 | 4 | 5 | 9 |
| 1998 | 4 | 10 | 14 |
| 1999 | 7 | 3 | 10 |
| 2000 | 6 | 5 | 11 |
| 2001 | 3 | 6 | 9 |
| 2002 | 2 | 5 | 7 |
| 2003 | 4 | 2 | 6 |
| 2004 | 2 | 3 | 5 |
| 2005 | 6 | 5 | 11 |
| 2006 | 1 | 2 | 3 |
| 2007 | 5 | 2 | 7 |
| 2008 | 4 | 2 | 6 |
| 2009 | 3 | 3 | 6 |
| 2010 | 6 | 1 | 7 |
| 2011 | 3 | 4 | 7 |
| 2012 | 2 | 3 | 5 |
| 2013 | 3 | 1 | 4 |
| 2014 | 5 | 1 | 6 |
| 2015 | 5 | 1 | 6 |
| 2016 | 4 | 2 | 6 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 2 | 4 |
| 2019 | 1 | 3 | 4 |
| 2020 | 0 | 8 | 8 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 1 | 1 |
Below are the most recent publications written about "Drug Resistance, Multiple" by people in Profiles.
-
Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance. Biochim Biophys Acta Mol Cell Res. 2023 03; 1870(3):119407.
-
Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation. Blood Cancer J. 2021 12 04; 11(12):194.
-
Antimicrobial blue light: A 'Magic Bullet' for the 21st century and beyond? Adv Drug Deliv Rev. 2022 01; 180:114057.
-
Transferrin Coated d-penicillamine-Au-Cu Nanocluster PLGA Nanocomposite Reverses Hypoxia-Induced EMT and MDR of Triple-Negative Breast Cancers. ACS Appl Bio Mater. 2021 06 21; 4(6):5033-5048.
-
Tuberculous Scleritis and Multidrug Resistance. Ocul Immunol Inflamm. 2022 May 19; 30(4):915-924.
-
Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/ß-catenin signaling regulation. Cell Oncol (Dordr). 2021 Apr; 44(2):405-422.
-
Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p. Sci Bull (Beijing). 2021 09 30; 66(18):1895-1905.
-
Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells. J Control Release. 2021 02 10; 330:1106-1117.
-
Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-?. Front Immunol. 2020; 11:582833.
-
Chemical strategies to overcome resistance against targeted anticancer therapeutics. Nat Chem Biol. 2020 08; 16(8):817-825.